RSG

Republic is a textbook high-quality defensive compounder. Revenue has climbed every year from $11.3B (FY2021) to $16.6B (FY2025), with net income rising in lockstep from $1.29B to $2.14B — durable, annuity-like waste/environmental-services cash flows. FY2025 operating margin held at 19.9% (flat vs. 2024 despite an $89M restructuring and a 12c/share labor-disruption hit), net margin is 12.9%, and ROE is a strong 17.9%. The growth engine is pricing, not volume: the MD&A attributes the 3.5% revenue gain to 4.1% average yield 'in excess of cost inflation' plus 1.3% from acquisitions, partially offset by -0.6% volume — and management explicitly reaffirms 'pricing in excess of cost inflation' as the 2026 strategy. Operating cash flow grew 9.1% to $4.30B against $1.89B capex, funding a 7.4% dividend increase to $738M and an 80.5% jump in buybacks to $870M (shares down 1.1%). This is a well-run, shareholder-friendly machine.

The problem is price, not quality. At $213.58 the stock trades at 31.2x FY2025 EPS of $6.85 and 4.0x sales — a premium multiple for a business management itself guides to grow adjusted EPS only ~3-4% next year ($7.20-7.28 vs. $7.02 in 2025; reported $7.14-7.22 vs. $6.85). On the high end of 2026 reported guidance ($7.22), the forward P/E is still ~29.6x. That is a rich growth-adjusted valuation: you are paying a low-30s multiple for high-single-digit total earnings growth. The quality is real and the multiple is defensible for a defensive name, but it leaves little margin of safety and limited upside from multiple expansion.